Identification
- Composition (DCI)
- irbesartanhydrchlorothiazide
- Manufacturer
- PHI
- ATC code
- C09DA04
- Presentation
- Boite de 30
- Schedule / Reimb.
- A
- Hospital price
- 100.50 MAD
Indications
IRPHI PLUS (Irbésartan+ Hydrochlorothiazide) est un antihypertenseur antagoniste de l’angiotensine II associé à un diurétique. C’est une association à dose fixe indiquée dans le traitement de l’hypertension artérielle essentielle chez les patients adultes dont la pression artérielle est insuffisamment contrôlée par l’irbésartan seul ou l’hydrochlorothiazide seul.
Find an open pharmacy
On-call pharmacies near you
About IRPHI PLUS 300 MG / 25 MG
IRPHI PLUS 300 MG / 25 MG is marketed in Morocco by PHI and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of IRPHI PLUS 300 MG / 25 MG, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about IRPHI PLUS 300 MG / 25 MG
Answers to common questions from Moroccan patients about this drug.